149 related articles for article (PubMed ID: 38387820)
1. Enhanced brain distribution of Ginsenoside F1 via intranasal administration in combination with absorption enhancers.
Mao Y; Yuan W; Gai J; Zhang Y; Wu S; Xu EY; Wang L; Zhang X; Guan J; Mao S
Int J Pharm; 2024 Apr; 654():123930. PubMed ID: 38387820
[TBL] [Abstract][Full Text] [Related]
2. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.
Zhang T; Li M; Han X; Nie G; Zheng A
AAPS PharmSciTech; 2022 May; 23(5):143. PubMed ID: 35578146
[TBL] [Abstract][Full Text] [Related]
3. [Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
Chen XM; Zhu JB; Sun WD; Zhang LJ
Yao Xue Xue Bao; 2006 Feb; 41(2):149-55. PubMed ID: 16671546
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
[TBL] [Abstract][Full Text] [Related]
5. [Feasibility study of ginsenoside Rg1 administrated via intranasal route].
Chen X
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):229-31. PubMed ID: 20394302
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
Na L; Mao S; Wang J; Sun W
Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
8. [Intranasal absorption of rivastigmine hydrogen tartrate and brain targeting evaluation].
Wang HM; Wei GG; Gao MY; Gu XQ; Mao SR
Yao Xue Xue Bao; 2016 Oct; 51(10):1616-21. PubMed ID: 29932610
[TBL] [Abstract][Full Text] [Related]
9. CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15.
Illum L; Jordan F; Lewis AL
J Control Release; 2012 Aug; 162(1):194-200. PubMed ID: 22709592
[TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
Liu S; Ho PC
J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.
Inoue D; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Higaki K; Tanaka A; Yutani R; Sakane T; Furubayashi T
Mol Pharm; 2018 Oct; 15(10):4462-4469. PubMed ID: 30165013
[TBL] [Abstract][Full Text] [Related]
12. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of disulfiram inclusion complex embedded in hydroxypropyl-β-cyclodextrin on intracranial glioma-bearing male rats via intranasal route.
Qu Y; Sun X; Ma L; Li C; Xu Z; Ma W; Zhou Y; Zhao Z; Ma D
Eur J Pharm Sci; 2021 Jan; 156():105590. PubMed ID: 33065226
[TBL] [Abstract][Full Text] [Related]
14. Intranasally administered thermosensitive gel for brain-targeted delivery of rhynchophylline to treat Parkinson's disease.
Lin H; Xie L; Lv L; Chen J; Feng F; Liu W; Han L; Liu F
Colloids Surf B Biointerfaces; 2023 Feb; 222():113065. PubMed ID: 36473372
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery.
Sherje AP; Londhe V
AAPS PharmSciTech; 2018 Jan; 19(1):384-394. PubMed ID: 28748368
[TBL] [Abstract][Full Text] [Related]
16. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
17. Effect of polysorbate 80 on the intranasal absorption and brain distribution of tetramethylpyrazine phosphate in rats.
Gao M; Mei D; Huo Y; Mao S
Drug Deliv Transl Res; 2019 Feb; 9(1):311-318. PubMed ID: 30168052
[TBL] [Abstract][Full Text] [Related]
18. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
Abdel-Bar HM; Abdel-Reheem AY; Awad GA; Mortada ND
J Pharm Pharm Sci; 2013; 16(3):456-69. PubMed ID: 24021293
[TBL] [Abstract][Full Text] [Related]
20. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
